Merck Canada Inc.
Merck Canada Inc. has met with MPs 20 times since January 2024, reaching 14 MPs across 2 parties. Most recent contact: August 25, 2026.
What they're asking for
In the registry's own words. Descriptions are only filed for meetings since mid-2024.
Policies and frameworks to accelerate access to innovative medicines post-Health Canada approval, including efforts to reduce time to reimbursement and streamline federal/provincial listing processes.
August 25, 2026 · Francis Scarpaleggia · Liberal · Health; Industry
Any and all free trade treaty agreements as it relates to the North American Free Trade Agreement (NAFTA) and trade negotiations between Canada as it relates to the European Union, India, Japan and the Trans-Pacific Partnership. International trade policies in support of the biopharmaceutical industry, including competitive and predictable intellectual property protection, product regulation and patient access to medicines.
June 30, 2026 · Mélanie Joly · Liberal · Health; Industry; Intellectual Property; International Trade; International Development
Policy measures to ensure security of drug supply in Canada and preserve Canada’s attractiveness for biopharmaceutical launches, including in response to foreign pricing regulations.
June 17, 2026 · Marjorie Michel · Liberal · Health; International Trade; Research and Development
Canada's Access to Medicines Regime with respect to ensuring that the program allows for the delivery of timely access to needed medicines to the developing world supported by a business climate in Canada that continues to encourage research into further treatment and prevention of disease.
February 23, 2026 · Karim Bardeesy · Liberal · Health; Industry; Intellectual Property; International Trade; Science and Technology
US - Canada Regulatory Cooperation Council (RCC) as it relates to the regulation of biopharmaceutical products.
October 23, 2025 · Ali Ehsassi · Liberal · International Trade; International Development
Patented Medicines (Notice of Compliance) Regulations with respect to ensuring that patent rights are respected and are internationally competitive.
October 21, 2025 · Maggie Chi · Liberal · Intellectual Property; International Trade
Full meeting log
20 MP-directed communications since January 2024, from the Registry of Lobbyists.
| Date | MP |
|---|---|
| 2026-08-25 | Francis Scarpaleggia · Liberal |
| 2026-06-30 | Mélanie Joly · Liberal |
| 2026-06-17 | Marjorie Michel · Liberal |
| 2026-06-02 | Aslam Rana · Liberal |
| 2026-05-26 | Ali Ehsassi · Liberal |
| 2026-04-15 | Maggie Chi · Liberal |
| 2026-04-02 | Marjorie Michel · Liberal |
| 2026-02-23 | Karim Bardeesy · Liberal |
| 2026-02-23 | Dominic LeBlanc · Liberal |
| 2026-02-23 | Marjorie Michel · Liberal |
| 2025-12-02 | Karim Bardeesy · Liberal |
| 2025-10-23 | Ali Ehsassi · Liberal |
| 2025-10-23 | Randy Hoback · Conservative |
| 2025-10-23 | Shelby Kramp-Neuman · Conservative |
| 2025-10-23 | Dominic LeBlanc · Liberal |
| 2025-10-21 | Maggie Chi · Liberal |
| 2025-10-21 | Karina Gould · Liberal |
| 2024-09-23 | Helena Jaczek · Liberal |
| 2024-05-25 | Blaine Calkins · Conservative |
| 2024-05-24 | Tom Kmiec · Conservative |